Exane Derivatives’s COPT Defense Properties CDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-121
Closed -$3.45K 827
2022
Q1
$3.45K Buy
+121
New +$3.26K ﹤0.01% 719
2021
Q1
Sell
-4,383
Closed -$114K 932
2020
Q4
$114K Sell
4,383
-1,093
-20% -$27.6K 0.03% 383
2020
Q3
$130K Buy
5,476
+456
+9% +$11.4K 0.04% 257
2020
Q2
$127K Buy
+5,020
New +$125K 0.03% 259
2018
Q4
Sell
-9,476
Closed -$283K 689
2018
Q3
$283K Buy
+9,476
New +$284K 0.05% 213
2017
Q4
Sell
-1
Closed -$33 616
2017
Q3
$33 Sell
1
-10
-91% -$334 ﹤0.01% 546
2017
Q2
$385 Hold
11
﹤0.01% 507
2017
Q1
$364 Sell
11
-24,018
-100% -$784K ﹤0.01% 442
2016
Q4
$750K Buy
24,029
+24,028
+2,402,800% +$682K 0.15% 113
2016
Q3
$28 Buy
+1
New +$29 ﹤0.01% 582

Other funds holding CDP

Exane Derivatives's CDP Position: Q2 2022 in Review

Exane Derivatives sold out of COPT Defense Properties (CDP) in Q2 2022, closing a stake of 121 shares — an estimated $3.45K sold.

Exane Derivatives first reported a position in CDP in Q3 2016 and held it in 10 quarters. The position peaked at $750K in Q4 2016. 256 funds tracked by Wall St. Rank hold CDP as of Q2 2022.

  • Exane Derivatives reported no remaining COPT Defense Properties position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 121 COPT Defense Properties shares in Q2 2022, an estimated $3.45K.
  • Exane Derivatives first reported a position in COPT Defense Properties in Q3 2016 and held it in 10 quarters.
  • Exane Derivatives's COPT Defense Properties position peaked at $750K in Q4 2016.
  • 256 funds tracked by Wall St. Rank held COPT Defense Properties as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.